These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35445836)

  • 1. Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers.
    Wakiyama H; Furusawa A; Okada R; Inagaki F; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Dec; 71(12):2869-2879. PubMed ID: 35445836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Choyke PL; Kobayashi H
    Adv Ther (Weinh); 2021 May; 4(5):. PubMed ID: 33997271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response.
    Kato T; Fukushima H; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Takao S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2152248. PubMed ID: 36465486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Effectiveness of IgG Antibody versus F(ab')
    Kato T; Okada R; Furusawa A; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2022 Oct; 19(10):3600-3611. PubMed ID: 35759343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared photoimmunotherapy and anti-cancer immunity.
    Nakajima K; Ogawa M
    Int Immunol; 2024 Feb; 36(2):57-64. PubMed ID: 37843836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
    Fukushima H; Furusawa A; Kato T; Wakiyama H; Takao S; Okuyama S; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2023 Oct; 22(10):1215-1227. PubMed ID: 37461129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.
    Okada R; Maruoka Y; Furusawa A; Inagaki F; Nagaya T; Fujimura D; Choyke PL; Kobayashi H
    Bioconjug Chem; 2019 Oct; 30(10):2624-2633. PubMed ID: 31498995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model.
    Furusawa A; Okada R; Inagaki F; Wakiyama H; Kato T; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Oncoimmunology; 2022; 11(1):2019922. PubMed ID: 35003897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-Infrared Photoimmunotherapy of Cancer.
    Kobayashi H; Choyke PL
    Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel Therapy Targeting the Cancer Microenvironment Using Near-Infrared Photoimmunotherapy Leading to Tumor Immune Activation].
    Kato T; Noma K; Furusawa A; Kobayashi H; Fujiwara T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1361-1363. PubMed ID: 38303275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment.
    Inagaki FF; Kano M; Furusawa A; Kato T; Okada R; Fukushima H; Takao S; Okuyama S; Choyke PL; Kobayashi H
    Cancer Sci; 2024 Jul; 115(7):2396-2409. PubMed ID: 38671582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.
    Kato T; Okada R; Furusawa A; Inagaki F; Wakiyama H; Furumoto H; Okuyama S; Fukushima H; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2021 Nov; 20(11):2262-2273. PubMed ID: 34518299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity.
    Kobayashi H; Furusawa A; Rosenberg A; Choyke PL
    Int Immunol; 2021 Jan; 33(1):7-15. PubMed ID: 32496557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond.
    Wei D; Qi J; Hamblin MR; Wen X; Jiang X; Yang H
    Theranostics; 2022; 12(16):7108-7131. PubMed ID: 36276636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.
    Kato T; Furusawa A; Okada R; Inagaki F; Wakiyama H; Furumoto H; Fukushima H; Okuyama S; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2023 Jan; 22(1):75-88. PubMed ID: 36223542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.
    Taki S; Matsuoka K; Nishinaga Y; Takahashi K; Yasui H; Koike C; Shimizu M; Sato M; Sato K
    J Immunother Cancer; 2021 Oct; 9(11):. PubMed ID: 34725216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.
    Fukushima H; Kato T; Furusawa A; Okada R; Wakiyama H; Furumoto H; Okuyama S; Kondo E; Choyke PL; Kobayashi H
    Cancer Sci; 2022 Sep; 113(9):3180-3192. PubMed ID: 35723065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.